CALCOCO2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.092000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.172000E-01
Normal-vs-Stage2
9.153200E-01
Normal-vs-Stage3
1.031370E-01
Normal-vs-Stage4
1.033380E-01
Stage1-vs-Stage2
8.912000E-02
Stage1-vs-Stage3
6.395600E-03
Stage1-vs-Stage4
7.390000E-01
Stage2-vs-Stage3
3.401700E-02
Stage2-vs-Stage4
8.546200E-02
Stage3-vs-Stage4
2.836800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.012000E-01
Normal-vs-AfricanAmerican
8.920400E-01
Normal-vs-Asian
6.467400E-01
Caucasian-vs-AfricanAmerican
8.171800E-01
Caucasian-vs-Asian
8.933800E-02
AfricanAmerican-vs-Asian
4.610200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.911600E-01
Normal-vs-Female
8.242600E-01
Male-vs-Female
7.508600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.234200E-01
Normal-vs-Age(41-60Yrs)
4.597600E-01
Normal-vs-Age(61-80Yrs)
9.308400E-01
Normal-vs-Age(81-100Yrs)
9.676800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.753600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.167600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.295400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.072050E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.723230E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.880200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.151600E-01
Normal-vs-Daily Drinker
6.183200E-01
Normal-vs-Weekly Drinker
7.585200E-01
Normal-vs-Occasional Drinker
5.100000E-01
Normal-vs-Social Drinker
6.672000E-01
Non Drinker-vs-Daily Drinker
6.748400E-01
Non Drinker-vs-Weekly Drinker
5.765400E-01
Non Drinker-vs-Occasional Drinker
5.874500E-02
Non Drinker-vs-Social Drinker
4.180300E-02
Daily Drinker-vs-Weekly Drinker
8.286400E-01
Daily Drinker-vs-Occasional Drinker
7.204300E-02
Daily Drinker-vs-Social Drinker
9.252200E-02
Weekly Drinker-vs-Occasional Drinker
8.580000E-02
Weekly Drinker-vs-Social Drinker
2.238400E-01
Occasional Drinker-vs-Social Drinker
2.014400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.983600E-01
Normal-vs-Grade 2
3.120400E-03
Normal-vs-Grade 3
2.855700E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.609400E-01
Grade 1-vs-Grade 3
3.667400E-01
Grade 1-vs-Grade 4
2.983600E-01
Grade 2-vs-Grade 3
9.906000E-01
Grade 2-vs-Grade 4
3.120400E-03
Grade 3-vs-Grade 4
2.855700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.552000E-01
Normal-vs-NonDiabetic
8.106800E-01
Diabetic-vs-NonDiabetic
1.377410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.403600E-01
Normal-vs-NoPancreatitis
8.754800E-01
Pancreatitis-vs-NoPancreatitis
9.967000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.138400E-01
Normal-vs-N1
9.179600E-01
N0-vs-N1
1.914420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.234200E-01
Normal-vs-TP53-NonMutant
6.456800E-01
TP53-Mutant-vs-TP53-NonMutant
3.790800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
